Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Sexually Transmitted Diseases (STD) specialty page provides STD-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Out-Of-Pocket Costs Hinder PrEP Use Among Young MSM in the Private Health Care System
One study takes a look at how out-of-pocket costs impede the use of pre-exposure prophylaxis in young men who have sex with men.
South Still Disproportionately Affected by HIV Despite Decline in Diagnoses
Dr. Meg Watson from the CDC reports updated information regarding the current rates and trends of HIV diagnoses in the South at 2018 CROI.
Bending & Ending the HIV Epidemic: Are We on Track to Meet 90-90-90 Goals?
At CROI 2018, Dr. Helen Weiss highlighted where we are in terms of meeting these goals, where the challenges are, and strategies to help prevent new infections.
Assessing Interest in New Antiretroviral Therapies May Help Inform Uptake & Adherence
In an oral abstract session at CROI 2018, Dr. Nathan Thielman stresses that understanding the interest of HIV-positive treatment-experienced individuals in new antiretroviral therapies may help inform their development and uptake.
Vaginal Microbiome May Influence Effectiveness of Pre-Exposure Prophylaxis
Better understanding of the vaginal microbiome may provide new insights into HIV acquisition.
Dolutegravir Effective and Well-Tolerated in HIV/TB Co-Infected Adults
Study results revealed that dolutegravir appears to be effective and well-tolerated in HIV/tuberculosis (TB) co-infected adults also receiving rifampin-based TB therapy.
CDC Finds PrEP Not Reaching Americans Who Need It, Particularly African Americans
First detailed analysis by race and risk group finds that two-thirds of those who could benefit from PrEP are African American or Latino, but they account for the smallest percentage of prescriptions to date.
Bictegravir Single-Dose Combo Found to Be As Safe & Effective As DTG/ABC/3TC
Week 48 safety results show that switching to B/F/TAF was noninferior to remaining on DTG/ABC/3TC.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.